Select your text size for this site here: Normal Text Medium Text Large Text

Details on our Success Rates for Patients with Pain and Sexual Dysfunction

Published Results

Ongoing and Unpublished Results

Decreasing intercourse pain

96% (Statistical significance P </= .002)

In a study published December, 2004 in the peer reviewed medical journal, Medscape General Medicine, Ob/Gyn and Women's Health, 96% of study participants reported decrease or complete elimination of intercourse pain. The criteria for entrance into this study included all women we treated who reported painful intercourse. We did not refuse participation to anyone, regardless of age or duration of the pain.

Improving sexual function

91% (Statistical significance P </= .003)

The same published study (Medscape General Medicine, Dec, 2004), measured various standardized categories of sexual dysfunction. Significant improvement was reported by women who came to us with decreased function in any of the following areas. The numbers represent the percent of women who reported improvement in these areas, after receiving this therapy.

Improved orgasm 56%
Improved satisfaction 65%
Improved lubrication 70%
Improved arousal 74%
Improved desire 78%
Improved sexual function (overall) 91%
Decreased intercourse pain 96%

Endometriosis and pelvic pain

Due to the side note that 65% of the women in this study reported diagnoses of endometriosis before treatment, we conducted research on improving sexual function and decreasing pain in patients with endometriosis.

In September 2006, the American Society for Reproductive Medicine (ASRM) invited us to present our work at its annual meeting. Fertility and Sterility published two study abstracts that examined our results decreasing pain and returning function in several areas of concern for women with endometriosis. These included menstrual pain, intercourse pain, and overall sexual function.

Menstrual pain

The published data reported significant improvements in pain levels throughout the menstrual cycle, six weeks after therapy. The most dramatic pain relief came at menstruation (P = 0.008), typically a time of greatest pain. Several study patients were surprised to be without menstrual pain for the first time in years.

Intercourse pain, sexual function

Relief from painful intercourse (dyspareunia) and sexual dysfunction (poor desire, arousal, lubrication, orgasm, or satisfaction) was significant in the published abstract. Our patients reported considerable relief in all six areas listed above, as measured in validated scientific tests. The greatest relief was during sexual intercourse (P<0.001), with all but one of the participants reporting decreased pain six weeks after therapy.

While there are no guarantees in any medical procedure, it is rare that we do not see a measurable result in our patients. Most of our patients speak of positive side-effects such as

In short, this therapy appears to resolve a significant number of longstanding issues. For most of our patients, this therapy just makes good sense. They reason that if we are able to decrease the internal adhesions that have formed over a lifetime of healing from infections, inflammations, surgeries, and trauma, their muscles and organs in that area will function better, and with less pain.